2003
DOI: 10.1097/00007435-200305000-00012
|View full text |Cite
|
Sign up to set email alerts
|

High Percentages of Resistance to Tetracycline and Penicillin and Reduced Susceptibility to Azithromycin Characterize the Majority of Strain Types of Neisseria gonorrhoeae Isolates in Cuba, 1995???1998

Abstract: This study demonstrates high percentages of N gonorrhoeae isolates with penicillin and tetracycline resistance in Cuba. As has been noted in other studies in the Caribbean region and Latin America, resistance and reduced susceptibility to azithromycin are developing as emerging problems. Since penicillin and tetracycline continue to be widely used for the treatment of gonococcal infections in Cuba, this study indicates the importance of antimicrobial susceptibility surveillance so that effective antibiotics ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0
2

Year Published

2005
2005
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(18 citation statements)
references
References 31 publications
0
16
0
2
Order By: Relevance
“…In Japan, infections caused by strains exhibiting decreased susceptibility to cefixime have failed to respond to therapy with a 200-mg dose of cefixime, which is one-half of the dose recommended in the United (7), and azithromycin is not recommended for use for the primary treatment of uncomplicated gonococcal infections because of the gastrointestinal intolerance of the 2-g dose (9). In addition, isolates with azithromycin MICs exceeding 1.0 g/ml have been isolated in the continental United States and Cuba, which suggests that this agent should not be recommended for use for the primary treatment of gonorrhea (17,24). Our study describes a QRNG outbreak in California that started in 2000 in which the main outbreak isolate was also CMRNG and had azithromycin MICs of 0.5 g/ml.…”
Section: Discussionmentioning
confidence: 94%
“…In Japan, infections caused by strains exhibiting decreased susceptibility to cefixime have failed to respond to therapy with a 200-mg dose of cefixime, which is one-half of the dose recommended in the United (7), and azithromycin is not recommended for use for the primary treatment of uncomplicated gonococcal infections because of the gastrointestinal intolerance of the 2-g dose (9). In addition, isolates with azithromycin MICs exceeding 1.0 g/ml have been isolated in the continental United States and Cuba, which suggests that this agent should not be recommended for use for the primary treatment of gonorrhea (17,24). Our study describes a QRNG outbreak in California that started in 2000 in which the main outbreak isolate was also CMRNG and had azithromycin MICs of 0.5 g/ml.…”
Section: Discussionmentioning
confidence: 94%
“…A possible alternative, spectinomycin, is not uniformly available. Currently, even in the developing countries, the overwhelming majority of the strains are still susceptible [166,168,169,172,180,182], but resistance, once used extensively, develops easily [183] making the drug an unlikely candidate as the first line treatment. Azithromycin could also be used, but resistance already exists, therefore, it is also unlikely to represent a safe choice in a much feared post-cephalosporin era [164].…”
Section: Neisseria Gonorrhoeaementioning
confidence: 99%
“…This initial study is promising, and further work may support the use of azithromycin monotherapy for the treatment of anaerobic PID. However, azithromycin is not an optimal regimen for the treatment of gonococcal PID, as increasing resistance is being reported [74][75][76][77][78][79][80]. Furthermore, although M. genitalium is susceptible to macrolides, azithromycin-resistant strains have recently been identified [49].…”
Section: Resultsmentioning
confidence: 99%